Global Drug-Eluting Stents Market

Dec 2020| MDS026A| BCC Publishing
Sample Report

Report Highlights

The global market for drug-eluting stents should grow from $6.7 billion in 2019 to $9.3 billion by 2024 at a compound annual growth rate (CAGR) of 6.8% during the period of 2019-2024.

Report Includes

  • 20 data tables and 18 additional tables
  • An overview of global market for drug-eluting stents within the medical devices industry
  • Estimation of the market size and analyses of market trends, with data from 2018 and 2019, and projections of compound annual growth rates (CAGRs) through 2024
  • Market share analysis of the drug-eluting stents based on product, application, end-use, and region
  • Identification of segments with high growth potential and analysis of future applications of each of the segments
  • Assessment of market dynamics for drug-eluting stents with market drivers and restraints explained, medical device regulations, market background and pipeline analysis of the stents
  • Coverage of prevalence and epidemiology of cardiovascular disease and description of coronary artery disease (CAD) and peripheral artery disease (PAD)
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
  • Company profiles of the leading market players, including Abbott, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corp., Medtronic Plc and Cook Medical Inc.

Report Scope

This report examines the current and projected market potential of drug-eluting stents. It offers a detailed analysis of the regulatory scenario, competitive environment, pipeline, technological advancement, drivers, restraints and market growth trends. The report also includes market projections through 2024 and the market rank for key market players. The report details the market share of drug-eluting stents based on types of product, application and end user.

By product type, the market is segmented into polymer-based drug-eluting stents and polymer-free drug-eluting stents. By application, the market is segmented into coronary artery disease (CAD) and peripheral artery disease (PAD). By end user, the market is segmented into hospitals, ambulatory surgical centers and specialty centers and clinics.

By geography, the market is segmented into North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa. Detailed analyses of major countries such as the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India are covered in regional segments. For market estimates, data is provided for 2018 as the base year, 2019 and forecast through year-end 2024. Estimated values used are based on drug-eluting stent manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.

Analyst Credentials

BCC Publishing Staff comprises expert analysts who are skilled in conducting primary research, secondary research and data analysis and have decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies. Collectively, the team represents a diverse set of educational achievements with individual graduate work completed in fields such as microbiology, electrical engineering, business administration and surgery, among others.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at
Title/Chapter NamePagesPrice Member Price
Full Report: Global Drug-Eluting Stents Market127 $2,750 Free
Chapter- 1: Introduction8Free DownloadFree
Chapter- 2: Summary and Highlights6$250Free
Chapter- 3: Medical Device Regulations8$177Free
Chapter- 4: Drug-Eluting Stents: Pipeline Analysis3$67Free
Chapter- 5: Drug-Eluting Stents: Market Background10$222Free
Chapter- 6: Drug-Eluting Stents: Market DynamicsFree DownloadFree
Chapter- 7: Impact of COVID-19 Pandemic5$111Free
Chapter- 8: Market Breakdown, by Product7$155Free
Chapter- 9: Market Breakdown, by Application8$177Free
Chapter- 10: Market Breakdown, by End User7$155Free
Chapter- 11: Market Breakdown, by Region32$710Free
Chapter- 12: Competitive Landscape5$111Free
Chapter- 13: Company Profiles25$554Free
Chapter- 14: Appendix: List of Acronyms3$67Free
Global Drug-Eluting Stents Market

Single User License: $2750

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries

Need a custom data table, graph or complete report? Tell us more.